close

Fundraisings and IPOs

1 2 3 74
Number of results: 1471
Date Company Amount Funding type Investors Therapeutic area Type of Information
2022-04-07 Kynos Therapeutics (UK) £6.5 million Epidarex Capital (US) Ip Group (UK) Scottish Enterprise (UK) Inflammatory diseases - Oncology - Metabolic diseases Financing round
2022-03-30 Vectivbio (Switzerland) up to a $75 million loan Kreos Capital (UK) Inflammatory diseases - Gastrointestinal diseases - Transplantation Loan
2021-12-27 Tetraneuron (Spain) 1million € loan Valencian Institute of Finance (Spain) FEDER (EU) Neurodegenerative diseases Loan
2021-09-09 Lexeo Therapeutics (USA-NY) $100 Million series B financing round D1 Capital Partners (USA-NY) Eventide Asset Management (USA-MA) CAM Capital (USA-NY) Verition Fund Management (USA-NY) Laurion Capital Management (USA-NY) Gray’s Creek Capital Partners (USA-CT) Longitude Capital (USA-CA) Omega Funds (USA-MA) Lundbeckfonden Ventures (DK) PBM Capital (USA-VA) Janus Henderson Investors (UK) Invus (USA-NY) Woodline Partners LP (USA-CA Alexandria Venture Investments (USA-CA) Rare diseases - Genetic diseases -Neurodegenerative diseases - Cardiovascular diseases Series B financing round
2021-06-09 Tetraneuron (Spain) more than €2.5 million financing round undisclosed private and specialised investors Neurodegenerative diseases Financing round
2021-05-26 Ysios Capital (Spain) €216 million ($260 million) Financing round European Investment Fund (EIF) European Guarantee Fund (EGF) Health Compartment of the Sustainable Development Umbrella Fund (SDUF) Financing round
2021-05-13 Splisense (IL) $28.5 million series B financing round Orbimed (IL) Israel Biotech Fund (IL) Biotel Limited (USA) Integra Holdings (IL) the Cystic Fibrosis Foundation (USA) Rare diseases - Genetic diseases - Pulmonary diseases Series B financing round
2021-05-13 Flare Therapeutics (USA - MA) $82 million series A financing round Third Rock Ventures (USA - MA) Boxer Capital (USA-CA) Nextech Invest (CH) Casdin Capital (USA-NY) Invus Financial Advisors (USA-NY) Eventide Asset Management (USA-MA) Neurological diseases - Inflammatory diseases - Immunological diseases - Rare diseases - Genetic diseases Series A financing round
2021-05-13 Flare Therapeutics (USA-MA) $82 million series A financing round Third Rock Ventures (USA-MA) Boxer Capital (USA-CA) Nextech Invest (CH) Casdin Capital (USA-CA) Invus Financial Advisors (USA-NY) Eventide Asset Management (USA-MA) Cancer-Oncology Series A financing round
2021-04-13 Vectivbio (Switzerland) $146.6 million IPO Inflammatory diseases - Gastrointestinal diseases - Transplantation IPO
2021-03-01 SalioGen Therapeutics (USA - MA) $20 Million series A financing round PBM Capital (USA - VA) and other undisclosed investors Cardiovascular diseases - Ophthalmological diseases Series A financing round
2021-02-11 Ensoma (USA - MA) $70 million series A financing round 5AM Ventures (USA – MA) F-Prime Capital (USA – MA) Takeda Ventures (USA – MA) Viking Global Investors (USA – CA) Cormorant Asset Management (USA – MA) RIT Capital Partners (UK) Symbiosis II (USA – MA) Alexandria Venture Investments (USA – CA) Cancer - Oncology - Autoimmune diseases - Infectious diseases Series A financing round
2021-01-07 Lexeo Therapeutics $85 Million series A financing round Longitude Capital (USA-CA) Omega Funds (USA-MA) Lundbeckfonden Ventures (DK) PBM Capital (USA-VA) Janus Henderson Investors (UK) Invus (USA-NY) Woodline Partners LP (USA-CA) the Alzheimer’s Drug Discovery Foundationi (USA-NY) Alexandria Venture Investments (USA-CA) Rare diseases - Genetic diseases -Neurodegenerative diseases - Cardiovascular diseases Series A financing round
2020-10-15 Vectivbio (Switzerland) $110 Million financing round Versant Ventures (USA) OrbiMed (USA) Novo Holdings (Denmark) BPI France (France) Tekla Healthcare Investors (USA) Inserm Transfer Initiative (France) Cowen Healthcare Investments (USA) Surveyor Capital (USA) Eventide Asset Management (USA) Inflammatory diseases - Gastrointestinal diseases - Transplantation Fundraising
2020-06-16 eTheRNA (Belgium) €34 M series B financing round LSP (the Netherlands), PMV (Belgium), Boehringer Ingelheim Venture Fund (Germany), Fund+ (Belgium), Omega Funds (USA), Grand Decade, a BVI subsidiary owned by China Grand Pharmaceutical and Healthcare Holdings Ltd; BNP Paribas Fortis Private Equity (Belgium), Yijing Capital (China), Novalis LifeSciences LLC (USA). Immunological diseases - Infectious diseases Series B financing round
2020-01-07 Vectivbio (Switzerland) $35 million fundraising Versant Ventures (USA) OrbiMed (USA) Novo Holdings (Denmark) BPI France (France) Tekla Healthcare Investors (USA) Inserm Transfer Initiative (France) Cowen Healthcare Investments (USA) Inflammatory diseases - Gastrointestinal diseases - Transplantation Fundraising
2019-07-24 20Med Therapeutics (NL) undisclosed grant European Eurostars Programme (EU) Rheumatic diseases - Inflammatory diseases Grant
2019-04-08 Sangamo Therapeutics (USA-CA) $136.3 million public offering Private placement
2018-10-18 Oxford Nanopore Technologies (UK) £50 million ( $66 million ) private placement Amgen (USA - CA) Technology - Services Private placement
2018-10-18 Krystal Biotech (USA - PA) $60.0 million private placement Rare diseases - Genetic diseases Private placement